Clinical Trial Update: Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating augmented Berlin-Frankfurt-Munster therapy for adolescents and young adults with acute lymphoblastic leukemia or acute lymphoblastic ly…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Lymphoblastic Lymphoma

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lymphoblastic Leukemia, Lymphoblastic Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2019-09-10